2 companies reported today. 1 beat estimates, 1 missed.
Maruti Suzuki India Automobile | ₹64,450 Cr | ₹13,545 Cr | +13.8% | +8.4% | Beat | -2.0% |
Dr. Reddy's Laboratories Healthcare | ₹19,704 Cr | ₹2,894 Cr | -9.2% | +11.5% | Miss | -6.5% |
Maruti Suzuki India reported Q2 FY27 net profit of ₹13,545 Cr on revenue of ₹64,450 Cr, with profit up +13.8% year-on-year and ahead of street estimates. The stock fell in reaction as investors weighed the margin trend and management's outlook for the rest of the year.
Dr. Reddy's Laboratories reported Q2 FY27 net profit of ₹2,894 Cr on revenue of ₹19,704 Cr, with profit down -9.2% year-on-year and short of street estimates. The stock fell in reaction as investors weighed the margin trend and management's outlook for the rest of the year.